The Inv€$tival Showcase offers up 7 presenting stages for startup, growth stage and publicly listed Biotech, Healthtech, Medtech, TechBio, Digital Health and Deeptech companies.
Mogrify is transforming the lives of patients through the development of a novel class of in vivo reprogramming therapies, initially addressing indications in ophthalmology, otology and metabolic and other areas of degenerative disease. Using its proprietary suite of platform technologies to systematically identify the key transcriptomic and epigenetic switches required to drive direct cellular reprogramming.
Connect with our team virtually at the 2023 Inv€$tival Showcase.